To The Moon

$Onconetix Inc.(ONCO)$

$Onconetix Inc.(ONCO) Rallies +7.96%: Micro-Cap Biotech Sees Volatile Rebound, $1.2 Resistance in Focus

Latest Close Data:

On 2026-04-09, ONCO closed at $1.22, up +7.96% from the previous close of $1.13. The stock is currently -98.4% below its 52-week high of $74.29.

Core Market Drivers:

1. The stock experienced extreme intraday volatility with a massive 148.68% trading range, likely driven by micro-cap speculation and short covering activity.

2. The company continues to operate with interim leadership (Karina Fedasz as CEO/CFO), highlighting ongoing corporate governance and operational uncertainty.

Technical Analysis:

• The trading volume was a massive 238 million shares (Volume Ratio: 226.21), indicating a frenzy of speculative interest.

• The MACD histogram (-0.0457) remains negative, showing a slight contraction in bearish momentum.

• The 6-day RSI (28.92) has rebounded from the deeply oversold territory below 25, suggesting a potential short-term relief rally.

Key Price Levels:

• Primary Support: $1.10 (Recent low and 52-week low).

• Strong Resistance: $1.20 (Recent resistance level from 2026-04-08).

• Immediate Pivot: $1.22 (Today's close, acting as immediate battleground).

Valuation Perspective:

The P/S ratio is 1.04, which is not directly comparable to profitable biotech peers due to the company's negative earnings (EPS TTM: -$82.81, P/E: -0.015). The Price-to-Book ratio of 0.05 suggests the market is valuing the company at a steep discount to its stated book value.

Analyst Targets:

Limited coverage. Currently, 1 analyst recommends a Hold rating. No average price target is available from the provided data.

Weekly Outlook:

Expect continued high volatility within a $1.10 - $1.50 range. A sustained break above the $1.20 resistance could target the $1.50 area, while a failure to hold $1.10 support may lead to a retest of the lows.

Risk Disclaimer: This content is for informational purposes only and not investment advice. Trading micro-cap stocks, especially those with negative fundamentals and extreme volatility like ONCO, carries a very high risk of loss. Please conduct your own due diligence.